{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:29:26Z","timestamp":1788791366757,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangxi Natural Science Foundation Joint Special Project","award":["2024GXNSFBA010207"],"award-info":[{"award-number":["2024GXNSFBA010207"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11418-026-02065-y","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:12:32Z","timestamp":1785219152000},"page":"1521-1537","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fufangteng Yixin Formula alleviates myocardial ischemia-reperfusion injury by modulating gut microbiota and resultant metabolites in rats"],"prefix":"10.1007","volume":"80","author":[{"given":"Fengyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilu","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"issue":"8","key":"2065_CR1","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/cir.0000000000001209","volume":"149","author":"SS Martin","year":"2024","unstructured":"Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL et al (2024) 2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation 149(8):e347\u2013e913. https:\/\/doi.org\/10.1161\/cir.0000000000001209","journal-title":"Circulation"},{"issue":"18","key":"2065_CR2","doi-asserted-by":"publisher","first-page":"14378","DOI":"10.3390\/ijms241814378","volume":"24","author":"BS Tudurachi","year":"2023","unstructured":"Tudurachi BS, Anghel L, Tudurachi A, Sasc\u0103u RA, St\u0103tescu C (2023) Assessment of inflammatory hematological ratios (NLR, PLR, MLR, LMR and monocyte\/HDL-cholesterol ratio) in acute myocardial infarction and particularities in young patients. Int J Mol Sci 24(18):14378. https:\/\/doi.org\/10.3390\/ijms241814378","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2065_CR3","doi-asserted-by":"publisher","first-page":"e70124","DOI":"10.1002\/clc.70124","volume":"48","author":"H Soleimani","year":"2025","unstructured":"Soleimani H, Najdaghi S, Davani DN, Dastjerdi P, Samimisedeh P, Shayesteh H et al (2025) Predicting in-hospital mortality in patients with acute myocardial infarction: a comparison of machine learning approaches. Clin Cardiol 48(4):e70124. https:\/\/doi.org\/10.1002\/clc.70124","journal-title":"Clin Cardiol"},{"issue":"6","key":"2065_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","volume":"33","author":"M Algoet","year":"2023","unstructured":"Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J et al (2023) Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med 33(6):357\u2013366. https:\/\/doi.org\/10.1016\/j.tcm.2022.02.005","journal-title":"Trends Cardiovasc Med"},{"key":"2065_CR5","doi-asserted-by":"publisher","unstructured":"Fede MS, Daziani G, Tavoletta F, Montana A, Compagnucci P, Goteri G et al (2025) Myocardial ischemia\/reperfusion injury: molecular insights, forensic perspectives, and therapeutic horizons. Cells 4(19):1509. https:\/\/doi.org\/10.3390\/cells14191509","DOI":"10.3390\/cells14191509"},{"issue":"22","key":"2065_CR6","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.jacc.2024.02.056","volume":"83","author":"FGP Welt","year":"2024","unstructured":"Welt FGP, Batchelor W, Spears JR, Penna C, Pagliaro P, Ibanez B et al (2024) Reperfusion injury in patients with acute myocardial infarction: JACC scientific statement. J Am Coll Cardiol 83(22):2196\u20132213. https:\/\/doi.org\/10.1016\/j.jacc.2024.02.056","journal-title":"J Am Coll Cardiol"},{"issue":"48","key":"2065_CR7","doi-asserted-by":"publisher","first-page":"e2409499","DOI":"10.1002\/advs.202409499","volume":"11","author":"H She","year":"2024","unstructured":"She H, Hu Y, Zhao G, Du Y, Wu Y, Chen W et al (2024) Dexmedetomidine ameliorates myocardial ischemia-reperfusion injury by inhibiting MDH2 lactylation via regulating metabolic reprogramming. Adv Sci (Weinh) 11(48):e2409499. https:\/\/doi.org\/10.1002\/advs.202409499","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"2065_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.medj.2023.12.007","volume":"5","author":"G Heusch","year":"2024","unstructured":"Heusch G (2024) Myocardial ischemia\/reperfusion: translational pathophysiology of ischemic heart disease. Med 5(1):10\u201331. https:\/\/doi.org\/10.1016\/j.medj.2023.12.007","journal-title":"Med"},{"key":"2065_CR9","doi-asserted-by":"publisher","first-page":"1085041","DOI":"10.3389\/fendo.2023.1085041","volume":"14","author":"J Zhen","year":"2023","unstructured":"Zhen J, Zhou Z, He M, Han HX, Lv EH, Wen PB et al (2023) The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases. Front Endocrinol (Lausanne) 14:1085041. https:\/\/doi.org\/10.3389\/fendo.2023.1085041","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"19","key":"2065_CR10","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1097\/cm9.0000000000002206","volume":"136","author":"X Chen","year":"2023","unstructured":"Chen X, Zhang H, Ren S, Ding Y, Remex NS, Bhuiyan MS et al (2023) Gut microbiota and microbiota-derived metabolites in cardiovascular diseases. Chin Med J (Engl) 136(19):2269\u20132284. https:\/\/doi.org\/10.1097\/cm9.0000000000002206","journal-title":"Chin Med J (Engl)"},{"key":"2065_CR11","doi-asserted-by":"publisher","unstructured":"Datta S, Pasham S, Inavolu S, Boini KM, Koka S (2024) Role of gut microbial metabolites in cardiovascular diseases-current insights and the road ahead. Int J Mol Sci 25(18):10208. https:\/\/doi.org\/10.3390\/ijms251810208","DOI":"10.3390\/ijms251810208"},{"key":"2065_CR12","doi-asserted-by":"publisher","unstructured":"Muttiah B, Hanafiah A (2025) Gut microbiota and cardiovascular diseases: unraveling the role of dysbiosis and microbial metabolites. Int J Mol Sci 26(9):4264. https:\/\/doi.org\/10.3390\/ijms26094264","DOI":"10.3390\/ijms26094264"},{"issue":"1","key":"2065_CR13","doi-asserted-by":"publisher","first-page":"10788","DOI":"10.1038\/s41467-024-55084-2","volume":"15","author":"Z Li","year":"2024","unstructured":"Li Z, Gu M, Zaparte A, Fu X, Mahen K, Mrdjen M et al (2024) Alcohol-induced gut microbial reorganization and associated overproduction of phenylacetylglutamine promotes cardiovascular disease. Nat Commun 15(1):10788. https:\/\/doi.org\/10.1038\/s41467-024-55084-2","journal-title":"Nat Commun"},{"issue":"6","key":"2065_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jgg.2021.12.007","volume":"49","author":"C Liu","year":"2022","unstructured":"Liu C, Sun Z, Shali S, Mei Z, Chang S, Mo H et al (2022) The gut microbiome and microbial metabolites in acute myocardial infarction. J Genet Genomics 49(6):569\u2013578. https:\/\/doi.org\/10.1016\/j.jgg.2021.12.007","journal-title":"J Genet Genomics"},{"issue":"6","key":"2065_CR15","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/cvr\/cvad023","volume":"119","author":"J Zhao","year":"2023","unstructured":"Zhao J, Zhang Q, Cheng W, Dai Q, Wei Z, Guo M et al (2023) Heart-gut microbiota communication determines the severity of cardiac injury after myocardial ischaemia\/reperfusion. Cardiovasc Res 119(6):1390\u20131402. https:\/\/doi.org\/10.1093\/cvr\/cvad023","journal-title":"Cardiovasc Res"},{"issue":"5","key":"2065_CR16","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/circulationaha.118.035235","volume":"139","author":"TWH Tang","year":"2019","unstructured":"Tang TWH, Chen HC, Chen CY, Yen CYT, Lin CJ, Prajnamitra RP et al (2019) Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation 139(5):647\u2013659. https:\/\/doi.org\/10.1161\/circulationaha.118.035235","journal-title":"Circulation"},{"key":"2065_CR17","doi-asserted-by":"publisher","first-page":"1625299","DOI":"10.3389\/fcvm.2025.1625299","volume":"12","author":"X Chen","year":"2025","unstructured":"Chen X, Ye L, Zou X, Zhou Y, Peng C, Huang R (2025) The role of gut microbiota in myocardial ischemia-reperfusion injury. Front Cardiovasc Med 12:1625299. https:\/\/doi.org\/10.3389\/fcvm.2025.1625299","journal-title":"Front Cardiovasc Med"},{"key":"2065_CR18","doi-asserted-by":"publisher","first-page":"123110","DOI":"10.1016\/j.lfs.2024.123110","volume":"358","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Deng J, Chen T, Liu S, Tang Y, Zhao JR et al (2024) Formononetin alleviates no reflow after myocardial ischemia-reperfusion via modulation of gut microbiota to inhibit inflammation. Life Sci 358:123110. https:\/\/doi.org\/10.1016\/j.lfs.2024.123110","journal-title":"Life Sci"},{"issue":"1","key":"2065_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12906-023-04013-9","volume":"23","author":"Y Cui","year":"2023","unstructured":"Cui Y, Zhang F, Xu W, Li Z, Zou J, Gao P et al (2023) Effects of Si-Miao-Yong-An decoction on myocardial I\/R rats by regulating gut microbiota to inhibit LPS-induced TLR4\/NF-\u03baB signaling pathway. BMC Complement Med Ther 23(1):180. https:\/\/doi.org\/10.1186\/s12906-023-04013-9","journal-title":"BMC Complement Med Ther"},{"issue":"4","key":"2065_CR20","first-page":"19","volume":"37","author":"B-L Chen","year":"2014","unstructured":"Chen B-L, Li C-L, Pan Z-X, Lei Y-L, Luo J-W, Jiang H-Z et al (2014) Observation on the therapeutic effect of Fufangteng Yixin Formula in treating angina pectoris of Qi deficiency and blood stasis type. Guangxi J Tradit Chin Med 37(4):19\u201321","journal-title":"Guangxi J Traditional Chin Med"},{"issue":"05","key":"2065_CR21","first-page":"621","volume":"36","author":"C-L Li","year":"2015","unstructured":"Li C-L, Jiang H-Z, Chen B-L, Lu J-Q, Pan Z-X, Wang Q-G (2015) The proliferative effect of Fufangteng Yixin Formula on the inner membrane microvascular endothelial cells of the human heart after hypoxia\/reoxygenation. Shaanxi J Tradit Chin Med 36(05):621\u2013623","journal-title":"Shaanxi J Traditional Chin Med"},{"issue":"06","key":"2065_CR22","first-page":"459","volume":"34","author":"C-L Li","year":"2015","unstructured":"Li C-L, Jiang H-Z, Chen B-L, Lu J-Q, Pan Z-X, Wang Q-G (2015) The protective mechanism of Fufangteng Yixin Formula on endocardial microvascular endothelial cells after ischemia-reperfusion injury. Shandong J Tradit Chin Med 34(06):459\u2013462","journal-title":"Shandong J Traditional Chin Med"},{"issue":"12","key":"2065_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17(12):773\u2013789. https:\/\/doi.org\/10.1038\/s41569-020-0403-y","journal-title":"Nat Rev Cardiol"},{"key":"2065_CR24","doi-asserted-by":"publisher","first-page":"1567339","DOI":"10.3389\/fmicb.2025.1567339","volume":"16","author":"Z Li","year":"2025","unstructured":"Li Z, Ye Y, Lai S, Bao J, Fu A (2025) Puerarin affects adipose lipolysis and ameliorates obesity by gut microbiota. Front Microbiol 16:1567339. https:\/\/doi.org\/10.3389\/fmicb.2025.1567339","journal-title":"Front Microbiol"},{"key":"2065_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jot.2022.08.009","volume":"35","author":"W Yang","year":"2022","unstructured":"Yang W, Gao B, Qin L, Wang X (2022) Puerarin improves skeletal muscle strength by regulating gut microbiota in young adult rats. J Orthop Translat 35:87\u201398. https:\/\/doi.org\/10.1016\/j.jot.2022.08.009","journal-title":"J Orthop Translat"},{"key":"2065_CR26","doi-asserted-by":"publisher","unstructured":"(2024) Puerarin alleviates atherosclerosis via the inhibition of Prevotella copri and its trimethylamine production. Gut 73(12):1934\u20131943. https:\/\/doi.org\/10.1136\/gutjnl-2024-331880","DOI":"10.1136\/gutjnl-2024-331880"},{"key":"2065_CR27","doi-asserted-by":"publisher","first-page":"155530","DOI":"10.1016\/j.phymed.2024.155530","volume":"128","author":"S Zhang","year":"2024","unstructured":"Zhang S, Chen Q, Jin M, Ren J, Sun X, Zhang Z et al (2024) Notoginsenoside R1 alleviates cerebral ischemia\/reperfusion injury by inhibiting the TLR4\/MyD88\/NF-\u03baB signaling pathway through microbiota-gut-brain axis. Phytomedicine 128:155530. https:\/\/doi.org\/10.1016\/j.phymed.2024.155530","journal-title":"Phytomedicine"},{"issue":"6","key":"2065_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jgr.2024.07.003","volume":"48","author":"X Xu","year":"2024","unstructured":"Xu X, Wu Q, Pei K, Zhang M, Mao C, Zhong X et al (2024) Ginsenoside Rg1 reduces cardiac inflammation against myocardial ischemia\/reperfusion injury by inhibiting macrophage polarization. J Ginseng Res 48(6):570\u2013580. https:\/\/doi.org\/10.1016\/j.jgr.2024.07.003","journal-title":"J Ginseng Res"},{"issue":"8","key":"2065_CR29","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1142\/s0192415x21500907","volume":"49","author":"GW Qin","year":"2021","unstructured":"Qin GW, Lu P, Peng L, Jiang W (2021) Ginsenoside Rb1 inhibits cardiomyocyte autophagy via PI3K\/Akt\/mTOR signaling pathway and reduces myocardial ischemia\/reperfusion injury. Am J Chin Med 49(8):1913\u20131927. https:\/\/doi.org\/10.1142\/s0192415x21500907","journal-title":"Am J Chin Med"},{"key":"2065_CR30","doi-asserted-by":"publisher","first-page":"6313625","DOI":"10.1155\/2017\/6313625","volume":"2017","author":"Q Zheng","year":"2017","unstructured":"Zheng Q, Bao XY, Zhu PC, Tong Q, Zheng GQ, Wang Y (2017) Ginsenoside Rb1 for myocardial ischemia\/reperfusion injury: preclinical evidence and possible mechanisms. Oxid Med Cell Longev 2017:6313625. https:\/\/doi.org\/10.1155\/2017\/6313625","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"2065_CR31","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.7150\/thno.43895","volume":"11","author":"L Jiang","year":"2021","unstructured":"Jiang L, Yin X, Chen YH, Chen Y, Jiang W, Zheng H et al (2021) Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia\/reperfusion injury through inhibiting ROS production from mitochondrial complex I. Theranostics 11(4):1703\u20131720. https:\/\/doi.org\/10.7150\/thno.43895","journal-title":"Theranostics"},{"key":"2065_CR32","doi-asserted-by":"publisher","first-page":"109913","DOI":"10.1016\/j.biopha.2020.109913","volume":"125","author":"CY Li","year":"2020","unstructured":"Li CY, Yang P, Jiang YL, Lin Z, Pu YW, Xie LQ et al (2020) Ginsenoside Rb1 attenuates cardiomyocyte apoptosis induced by myocardial ischemia reperfusion injury through mTOR signal pathway. Biomed Pharmacother 125:109913. https:\/\/doi.org\/10.1016\/j.biopha.2020.109913","journal-title":"Biomed Pharmacother"},{"key":"2065_CR33","doi-asserted-by":"publisher","first-page":"853981","DOI":"10.3389\/fcimb.2022.853981","volume":"12","author":"Z Chen","year":"2022","unstructured":"Chen Z, Zhang Z, Liu J, Qi H, Li J, Chen J et al (2022) Gut microbiota: therapeutic targets of ginseng against multiple disorders and ginsenoside transformation. Front Cell Infect Microbiol 12:853981. https:\/\/doi.org\/10.3389\/fcimb.2022.853981","journal-title":"Front Cell Infect Microbiol"},{"key":"2065_CR34","doi-asserted-by":"publisher","first-page":"990476","DOI":"10.3389\/fphar.2022.990476","volume":"13","author":"B Xie","year":"2022","unstructured":"Xie B, Zu X, Wang Z, Xu X, Liu G, Liu R (2022) Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites. Front Pharmacol 13:990476. https:\/\/doi.org\/10.3389\/fphar.2022.990476","journal-title":"Front Pharmacol"},{"key":"2065_CR35","doi-asserted-by":"publisher","first-page":"178091","DOI":"10.1016\/j.ejphar.2025.178091","volume":"1005","author":"X Xie","year":"2025","unstructured":"Xie X, Ge W, Luo Y, Xing X, Sun X (2025) Ginsenoside Rb3 modulates gut microbiota to alleviate cerebral inflammation and ferroptosis via the NLRP3\/NF-\u03baB\/GPX4 pathway in rats with cerebral ischemia\/reperfusion injury. Eur J Pharmacol 1005:178091. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178091","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2065_CR36","doi-asserted-by":"publisher","first-page":"e24354","DOI":"10.1002\/jcla.24354","volume":"36","author":"I Khan","year":"2022","unstructured":"Khan I, Khan I, Jianye Z, Xiaohua Z, Khan M, Hilal MG et al (2022) Exploring blood microbial communities and their influence on human cardiovascular disease. J Clin Lab Anal 36(4):e24354. https:\/\/doi.org\/10.1002\/jcla.24354","journal-title":"J Clin Lab Anal"},{"key":"2065_CR37","doi-asserted-by":"publisher","unstructured":"Nkosi BVZ, Padayachee T, Gront D, Nelson DR, Syed K (2022) Contrasting health effects of bacteroidetes and firmicutes lies in their genomes: analysis of P450s, ferredoxins, and secondary metabolite clusters. Int J Mol Sci 23(9):5057. https:\/\/doi.org\/10.3390\/ijms23095057","DOI":"10.3390\/ijms23095057"},{"issue":"2","key":"2065_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F (2024) Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 19(2):275\u2013293. https:\/\/doi.org\/10.1007\/s11739-023-03374-w","journal-title":"Intern Emerg Med"},{"key":"2065_CR39","doi-asserted-by":"publisher","unstructured":"Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P et al (2020) The firmicutes\/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients? Nutrients 12(5):1474. https:\/\/doi.org\/10.3390\/nu12051474","DOI":"10.3390\/nu12051474"},{"key":"2065_CR40","doi-asserted-by":"publisher","unstructured":"Kara\u010di\u0107 A, Renko I, Krznari\u0107 \u017d, Klobu\u010dar S, Liberati Pr\u0161o AM (2024) The association between the firmicutes\/bacteroidetes ratio and body mass among european population with the highest proportion of adults with obesity: an observational follow-up study from croatia. Biomedicines 12(10):2263. https:\/\/doi.org\/10.3390\/biomedicines12102263","DOI":"10.3390\/biomedicines12102263"},{"issue":"1","key":"2065_CR41","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12916-025-04203-x","volume":"23","author":"Y Liang","year":"2025","unstructured":"Liang Y, Zhao L, Zhang X, Liu S, Lu P, Wang J et al (2025) Lactobacillus ameliorates myocardial ischemia reperfusion injury by attenuating apoptosis, inflammation, oxidative stress, and ferroptosis. BMC Med 23(1):377. https:\/\/doi.org\/10.1186\/s12916-025-04203-x","journal-title":"BMC Med"},{"issue":"2","key":"2065_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.11909\/j.issn.1671-5411.2022.02.009","volume":"19","author":"JJ Cai","year":"2022","unstructured":"Cai JJ, Liu Y, Wang J, Wang JX, Wang Y, Xu SB et al (2022) Lactobacillus levels and prognosis of patients with acute myocardial infarction. J Geriatr Cardiol 19(2):101\u2013114. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2022.02.009","journal-title":"J Geriatr Cardiol"},{"key":"2065_CR43","doi-asserted-by":"publisher","first-page":"740483","DOI":"10.1016\/j.aquaculture.2023.740483","volume":"581","author":"Z Fan","year":"2024","unstructured":"Fan Z, Ke X, Jiang L, Zhang Z, Yi M, Liu Z et al (2024) Genomic and biochemical analysis reveals fermented product of a putative novel Romboutsia species involves the glycometabolism of tilapia. Aquaculture 581:740483. https:\/\/doi.org\/10.1016\/j.aquaculture.2023.740483","journal-title":"Aquaculture"},{"issue":"1","key":"2065_CR44","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12866-022-02498-x","volume":"22","author":"Z Li","year":"2022","unstructured":"Li Z, Ding L, Zhu W, Hang S (2022) Effects of the increased protein level in small intestine on the colonic microbiota, inflammation and barrier function in growing pigs. BMC Microbiol 22(1):172. https:\/\/doi.org\/10.1186\/s12866-022-02498-x","journal-title":"BMC Microbiol"},{"key":"2065_CR45","doi-asserted-by":"publisher","unstructured":"Priori EC, Ratto D, De Luca F, Sandionigi A, Savino E, Giammello F et al (2023) Hericium erinaceus extract exerts beneficial effects on gut-neuroinflammaging-cognitive axis in elderly mice. Biol (Basel) 13(1):18. https:\/\/doi.org\/10.3390\/biology13010018","DOI":"10.3390\/biology13010018"},{"issue":"1","key":"2065_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1832857","volume":"12","author":"L Ma","year":"2020","unstructured":"Ma L, Ni Y, Wang Z, Tu W, Ni L, Zhuge F et al (2020) Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice. Gut Microbes 12(1):1\u201319. https:\/\/doi.org\/10.1080\/19490976.2020.1832857","journal-title":"Gut Microbes"},{"issue":"1","key":"2065_CR47","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1038\/s41467-022-30240-8","volume":"13","author":"R Wang","year":"2022","unstructured":"Wang R, Yang X, Liu J, Zhong F, Zhang C, Chen Y et al (2022) Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun 13(1):2522. https:\/\/doi.org\/10.1038\/s41467-022-30240-8","journal-title":"Nat Commun"},{"issue":"5","key":"2065_CR48","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1007\/s12602-025-10475-9","volume":"17","author":"MO Cristina","year":"2025","unstructured":"Cristina MO, Elizabeth BR, Jose RM, Berenice PG, Diego Z, Luis CJ (2025) Mechanisms and therapeutic potential of key anti-inflammatory metabiotics: trans-vaccenic acid, indole-3-lactic acid, thiamine, and butyric acid. Probiotics Antimicrob Proteins 17(5):2805\u20132818. https:\/\/doi.org\/10.1007\/s12602-025-10475-9","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"8","key":"2065_CR49","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.cell.2024.03.014","volume":"187","author":"C Li","year":"2024","unstructured":"Li C, Stra\u017ear M, Mohamed AMT, Pacheco JA, Walker RL, Lebar T et al (2024) Gut microbiome and metabolome profiling in Framingham heart study reveals cholesterol-metabolizing bacteria. Cell 187(8):1834\u201352e19. https:\/\/doi.org\/10.1016\/j.cell.2024.03.014","journal-title":"Cell"},{"key":"2065_CR50","doi-asserted-by":"publisher","unstructured":"Sun L, Jia H, Li J, Yu M, Yang Y, Tian D et al (2019) Cecal gut microbiota and metabolites might contribute to the severity of acute myocardial ischemia by impacting the intestinal permeability, oxidative stress, and energy metabolism. Front Microbiol 10:1745. https:\/\/doi.org\/10.3389\/fmicb.2019.01745","DOI":"10.3389\/fmicb.2019.01745"},{"issue":"2","key":"2065_CR51","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cell.2014.09.035","volume":"159","author":"MM Yore","year":"2014","unstructured":"Yore MM, Syed I, Moraes-Vieira PM, Zhang T, Herman MA, Homan EA et al (2014) Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell 159(2):318\u2013332. https:\/\/doi.org\/10.1016\/j.cell.2014.09.035","journal-title":"Cell"},{"issue":"8","key":"2065_CR52","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1111\/dom.15686","volume":"26","author":"SM Ong","year":"2024","unstructured":"Ong SM, Ng DZW, Chee TEZ, Sng AA, Heng CK, Lee YS et al (2024) Plasma fatty acid esters of hydroxy fatty acids and surrogate fatty acid esters of hydroxy fatty acids hydrolysis activity in children with or without obesity and in adults with or without coronary artery disease. Diabetes Obes Metab 26(8):3429\u20133438. https:\/\/doi.org\/10.1111\/dom.15686","journal-title":"Diabetes Obes Metab"},{"key":"2065_CR53","doi-asserted-by":"publisher","unstructured":"Dongoran RA, Lin TJ, Byekyet A, Tang SC, Yang JH, Liu CH (2020) Determination of major endogenous FAHFAs in healthy human circulation: the correlations with several circulating cardiovascular-related biomarkers and anti-inflammatory effects on RAW 264.7 cells. Biomolecules 10(12):1689. https:\/\/doi.org\/10.3390\/biom10121689","DOI":"10.3390\/biom10121689"},{"key":"2065_CR54","doi-asserted-by":"publisher","first-page":"114827","DOI":"10.1016\/j.biopha.2023.114827","volume":"163","author":"H Tian","year":"2023","unstructured":"Tian H, Zhao X, Zhang Y, Xia Z (2023) Abnormalities of glucose and lipid metabolism in myocardial ischemia-reperfusion injury. Biomed Pharmacother 163:114827. https:\/\/doi.org\/10.1016\/j.biopha.2023.114827","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2065_CR55","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s13668-024-00564-6","volume":"13","author":"X Wang","year":"2024","unstructured":"Wang X, Dong Y, Huang R, Wang F, Xie J, Liu H et al (2024) The role of short-chain fatty acids in myocardial ischemia-reperfusion injury. Curr Nutr Rep 13(4):701\u2013708. https:\/\/doi.org\/10.1007\/s13668-024-00564-6","journal-title":"Curr Nutr Rep"},{"key":"2065_CR56","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.freeradbiomed.2024.11.054","volume":"227","author":"Y Cai","year":"2025","unstructured":"Cai Y, Yu Y, Zhang T, Qian B, Wang B, Yan W et al (2025) GATAD1 is involved in sphingosylphosphorylcholine-attenuated myocardial ischemia-reperfusion injury by modulating myocardial fatty acid oxidation and glucose oxidation. Free Radic Biol Med 227:166\u2013178. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.11.054","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"2065_CR57","doi-asserted-by":"publisher","first-page":"e00889","DOI":"10.1128\/mBio.00889-14","volume":"5","author":"M Vital","year":"2014","unstructured":"Vital M, Howe AC, Tiedje JM (2014) Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. mBio 5(2):e00889. https:\/\/doi.org\/10.1128\/mBio.00889-14","journal-title":"mBio"},{"issue":"1","key":"2065_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12934-016-0598-0","volume":"15","author":"AM de Las Heras","year":"2016","unstructured":"de Las Heras AM, Portugal-Nunes DJ, Rizza N, Sandstr\u00f6m AG, Gorwa-Grauslund MF (2016) Anaerobic poly-3-D-hydroxybutyrate production from xylose in recombinant Saccharomyces cerevisiae using a NADH-dependent acetoacetyl-CoA reductase. Microb Cell Fact 15(1):197. https:\/\/doi.org\/10.1186\/s12934-016-0598-0","journal-title":"Microb Cell Fact"},{"key":"2065_CR59","doi-asserted-by":"publisher","first-page":"1608658","DOI":"10.3389\/fcvm.2025.1608658","volume":"12","author":"Q Xu","year":"2025","unstructured":"Xu Q, Liu X, Wang Z, Li X, Jiang Q, Xu M (2025) Recent advancements and comprehensive analyses of butyric acid in cardiovascular diseases. Front Cardiovasc Med 12:1608658. https:\/\/doi.org\/10.3389\/fcvm.2025.1608658","journal-title":"Front Cardiovasc Med"},{"key":"2065_CR60","doi-asserted-by":"publisher","unstructured":"Biswas S, Hilser JR, Woodward NC, Wang Z, Gukasyan J, Nemet I et al (2025) Exploring the role of glycine metabolism in coronary artery disease: insights from human genetics and mouse models. Nutrients 17(1):198. https:\/\/doi.org\/10.3390\/nu17010198","DOI":"10.3390\/nu17010198"},{"issue":"2","key":"2065_CR61","first-page":"201","volume":"3","author":"GE Quintanilla-Villanueva","year":"2024","unstructured":"Quintanilla-Villanueva GE, Rodr\u00edguez-Delgado MM, Villarreal-Chiu JF, Blanco-G\u00e1mez EA, Luna-Moreno D (2024) The role of amino acid glycine on cardiovascular health and its beneficial effects. Narrat Rev 3(2):201\u2013211","journal-title":"Narrative Rev"},{"issue":"1","key":"2065_CR62","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1378\/chest.125.1.228","volume":"125","author":"CH Yeh","year":"2004","unstructured":"Yeh CH, Pang JH, Wu YC, Wang YC, Chu JJ, Lin PJ (2004) Differential-display polymerase chain reaction identifies nicotinamide adenine dinucleotide-ubiquinone oxidoreductase as an ischemia\/reperfusion-regulated gene in cardiomyocytes. Chest 125(1):228\u2013235. https:\/\/doi.org\/10.1378\/chest.125.1.228","journal-title":"Chest"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-026-02065-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-026-02065-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-026-02065-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:03:14Z","timestamp":1788789794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-026-02065-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2065"],"URL":"https:\/\/doi.org\/10.1007\/s11418-026-02065-y","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments comply with the ARRIVE guidelines and carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010\/63\/EU for animal experiments, or the National Institutes of Health guide for the care and use of Laboratory animals (NIH Publications No. 8023, revised 1978). This study was conducted in accordance with the principles on ethical animal research outlined in the Basel Declaration and the ethical guidelines by the International Council for Laboratory Animal Science (ICLAS). The animal experiment procedures were performed according to the Institutional Guidelines and Animal Ordinance of the Department of Health. All the animal experiments were approved by the Experimental animal Ethics Committee of Yangzhou University (NO. 202507048).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}